NEWS
ABX474 - find out more about our products at ABX.
April 16, 2025
Tosyl-Fallypride - find out more about our products at ABX.
March 20, 2025
FAZA precursor - find out more about our products at ABX.
February 13, 2025
ABX is member of the new Radiopharmacy Cluster Dresden named nukliD®
January 16, 2025
MIBG Hemisulfate - find out more about our products at ABX.
January 14, 2025
Explore our overview of monthly highlights featuring unique compounds.
January 13, 2025
ABX will be attending several major nuclear medicine congresses this year.
January 7, 2025
MBCTT - find out more about our products at ABX
November 29, 2024
precursor for radiometal-labelled RGD-peptider - find out more about our products at ABX
October 30, 2024
n.c.a. Nucleophilic F-L-DOPA precursor - find out more about our products at ABX
September 30, 2024
SynVesT-2 tin precursor - find out more about our products at ABX
August 31, 2024
Marco Müller (PhD) took over the General Management of ABX on August 1st, 2024.
August 13, 2024
TE-TDDPN - find out more about our products at ABX
July 31, 2024
Tetrofosmin sulfosalicylate - find out more about our products at ABX
June 28, 2024
[¹⁸F]FET precursor - find out more about our products at ABX
May 31, 2024
FPG precursor - find out more about our new products at ABX
April 30, 2024
TetraBoc-L-DOPA methyl ester - find out more about our new products at ABX
March 31, 2024
DFO* derivatives - find out more about our new products at ABX
FEBRUARY 29, 2024
Sifalin-TATE - find out more about our new products at ABX
JANUARY 31, 2024
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany!
NOVEMBER 08, 2023
Bye Bye SNMMI, Bye Bye Chicago - thank you for having us.
JULY 06, 2023
Looking to catch up with ABX? Let’s meet up!
JUNE 20, 2023
We are excited to share our brand-new website with you!
MAY 08, 2023
